Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chongguang Chen

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Pharmacology|April 17, 2007
Regulator of G protein signaling proteins differentially modulate signaling of mu and delta opioid receptorsZhihua Xie, Zhisong Li, Lei Guo, et al.
Science (New York, N.Y.)|June 23, 2018
In vivo brain GPCR signaling elucidated by phosphoproteomicsJeffrey J Liu, Kirti Sharma, Luca Zangrandi, et al.
International Journal of Molecular Sciences|November 9, 2024
Conformational Plasticity Enhances the Brain Penetration of a Metabolically Stable, Dual-Functional Opioid-Peptide CycloAntYangmei Li, William E Cotham, Abbe Eliasof, et al.
Biochemical and Biophysical Research Communications|November 6, 2007
Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptorPeng Huang, Chongguang Chen, Wei Xu, et al.
Neuropharmacology|January 25, 2025
Pharmacological characterization of the novel selective kappa opioid receptor agonists 10-Iodo-Akuammicine and 10-Bromo-akuammicine in miceKathryn Bland, Chongguang Chen, Peng Huang, et al.
Eneuro|June 21, 2020
Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensional Brain Imaging via CLARITYChongguang Chen, Alex H Willhouse, Peng Huang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 8, 2018
Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversionJeffrey J Liu, Yi-Ting Chiu, Kelly M DiMattio, et al.
Plos One|December 19, 2022
A novel Oprm1-Cre mouse maintains endogenous expression, function and enables detailed molecular characterization of μ-opioid receptor cellsJuliet Mengaziol, Amelia D Dunn, Gregory Salimando, et al.
European Journal of Pharmacology|November 20, 2019
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorderYi Zheng, Samuel Obeng, Bethany A Reinecke, et al.
Bioorganic Chemistry|February 25, 2021
Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptorsBoshi Huang, Rama Gunta, Huiqun Wang, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Pharmacology|April 17, 2007
Regulator of G protein signaling proteins differentially modulate signaling of mu and delta opioid receptorsZhihua Xie, Zhisong Li, Lei Guo, et al.
Science (New York, N.Y.)|June 23, 2018
In vivo brain GPCR signaling elucidated by phosphoproteomicsJeffrey J Liu, Kirti Sharma, Luca Zangrandi, et al.
International Journal of Molecular Sciences|November 9, 2024
Conformational Plasticity Enhances the Brain Penetration of a Metabolically Stable, Dual-Functional Opioid-Peptide CycloAntYangmei Li, William E Cotham, Abbe Eliasof, et al.
Biochemical and Biophysical Research Communications|November 6, 2007
Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptorPeng Huang, Chongguang Chen, Wei Xu, et al.
Neuropharmacology|January 25, 2025
Pharmacological characterization of the novel selective kappa opioid receptor agonists 10-Iodo-Akuammicine and 10-Bromo-akuammicine in miceKathryn Bland, Chongguang Chen, Peng Huang, et al.
Eneuro|June 21, 2020
Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensional Brain Imaging via CLARITYChongguang Chen, Alex H Willhouse, Peng Huang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 8, 2018
Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversionJeffrey J Liu, Yi-Ting Chiu, Kelly M DiMattio, et al.
Plos One|December 19, 2022
A novel Oprm1-Cre mouse maintains endogenous expression, function and enables detailed molecular characterization of μ-opioid receptor cellsJuliet Mengaziol, Amelia D Dunn, Gregory Salimando, et al.
European Journal of Pharmacology|November 20, 2019
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorderYi Zheng, Samuel Obeng, Bethany A Reinecke, et al.
Bioorganic Chemistry|February 25, 2021
Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptorsBoshi Huang, Rama Gunta, Huiqun Wang, et al.
Pageof 5